Hematologic disease treatment for leukemia focuses on controlling abnormal blood cell growth, protecting healthy cells, and helping patients move toward remission. Leukemia affects the blood and bone marrow, where the body forms blood cells. An oncologist can evaluate the type of leukemia, the pace of the disease, and the patient's overall health before recommending a personalized care plan.
Leukemia begins when blood-forming cells develop abnormal changes and grow uncontrollably. These abnormal cells can crowd the bone marrow and interfere with the production of normal red blood cells, white blood cells, and platelets. As a result, patients may experience fatigue, frequent infections, easy bruising, bleeding, fever, or unexplained weight changes.
According to the American Association for Cancer Research (AARC), there are four major types of leukemia. Each type behaves differently:
Since each cancer involves different cell types, treatment decisions for hematologic diseases depend heavily on the specific type. The oncologist will perform blood tests, bone marrow testing, genetic studies, and imaging to better understand the disease and its stage.
Once the oncologist provides a formal diagnosis, they will quickly move to personalizing a hematologic disease treatment plan. A patient’s plan may include one or more of the following:
Chemotherapy remains a common treatment option for many types of leukemia. These medications target rapidly dividing cancer cells and may be given by vein, by mouth, or into the fluid around the brain and spinal cord when needed. The goal may involve reducing leukemia cell counts, restoring healthy blood cell production, or helping the patient achieve remission.
Some chemotherapy treatment plans use phases. These phases may include induction therapy to reduce leukemia cell counts, consolidation therapy to lower the risk of recurrence, and maintenance therapy to keep the disease under control. However, the exact schedule depends on the type of leukemia, treatment response, and the patient’s overall condition.
Targeted therapy uses medications that target specific changes within leukemia cells. These medications may block signals that help cancer cells grow or survive. Precision medicine helps oncologists choose treatment based on the leukemia's genetic or molecular features. Testing can reveal markers that guide medication selection and help predict response. This approach allows hematologic disease treatment to be more individualized and may help reduce unnecessary exposure to treatments that are less likely to be effective.
Immunotherapy helps the immune system recognize and attack cancer cells. Some treatments use antibodies that attach to leukemia cells and help the immune system respond. Other approaches, such as certain cellular therapies, may train immune cells to better identify cancer cells. Immunotherapy may be an option for select patients based on leukemia type, previous treatment response, and overall health.
The oncologist may consider a stem cell transplant for some patients with higher-risk or relapsed leukemia. This treatment increases the success rate of intensive therapy and then restores blood-forming cells with healthy stem cells, but the process requires careful planning because it can involve significant risks and a longer recovery period. Note that not every patient is a candidate for transplant, as the oncologist will consider age, organ function, donor availability, leukemia type, and treatment response.
Supportive care helps patients manage symptoms, side effects, and complications during leukemia treatment. This care may include blood transfusions, antibiotics, anti-nausea medication, nutrition support, and monitoring for infection. Supportive care does not replace cancer treatment, but it helps patients tolerate therapy more safely and comfortably.
Common supportive care goals include:
The oncologist may also recommend regular lab testing to track blood counts and organ function. These results guide treatment adjustments and enable the team to respond quickly to changes. Ongoing communication can help patients report symptoms early and receive timely support.
Leukemia care does not end after the first treatment phase. Follow-up testing helps the oncologist determine whether treatment is reducing leukemia cells and supporting healthier blood production. Additional bone marrow exams, blood tests, and specialized monitoring may show how well the disease responds. Long-term follow-up also helps detect recurrence, manage late side effects, and support overall health.
Hematologic disease treatment for leukemia can include chemotherapy, targeted therapy, immunotherapy, stem cell transplantation, and supportive care. Our oncologist can evaluate the type of leukemia, genetic markers, symptoms, blood counts, and overall health to guide treatment decisions. If you have been suspected of or recently diagnosed with leukemia, contact our office to begin receiving personalized treatment.
Request an appointment here: https://lindenbergcancer.com or call Lindenberg Cancer & Hematology Center at (856) 475-0876 for an appointment in our Marlton office.
Check out what others are saying about our services on Yelp: Hematologic Disease Treatment in Marlton, NJ.
Colon cancer treatment can bring up a lot of questions for patients and their loved ones, particularly in the days after diagnosis. On top of everything else, the process introduces new terms, involves several specialists, and entails important decisions about next steps. While that can feel like a lot to take in, each part of…
Finishing a gynecological cancer treatment is a major milestone. However, you might feel unsure about what to expect during recovery, as the road ahead brings distinct changes. This period involves physical adjustments, emotional shifts, and a steady return to regular life. Understanding what to expect in these post-treatment steps provides a reliable map for the weeks…
Navigating a complex health diagnosis requires a clear understanding of what lies ahead, especially since gastrointestinal cancer treatment involves a highly personalized combination of therapies rather than a single procedure. Everyone follows a unique path because the digestive system comprises several distinct organs, including the stomach, colon, rectum, esophagus, and pancreas. Our oncology center focuses…
Prostate cancer treatment does not always involve removing the prostate. Many patients have more than one treatment option depending on the cancer’s stage, grade, growth pattern, and overall health. For some, active surveillance, radiation therapy, hormone therapy, or combination treatment may control the cancer effectively; for others, surgery remains the best choice. From an oncologist’s…
An oncologist can explain the diagnosis, review the available options, and help patients move forward…
The road after gynecological cancer treatment involves distinct steps of physical repair, emotional growth, and…
Embracing a personalized, structured plan for gastrointestinal cancer treatment gives patients the best opportunity to…
For some patients, the best approach is prostate removal; for others, it could be active…
Finishing lung cancer treatment marks a massive milestone. However, the transition into remission can raise…
Facing a diagnosis like this is life-changing, but the advancements in acute lymphocytic leukemia treatment…
